The role of oxidative protein modification and the gluthatione system in modulation of the redox status of breast epithelial cells
The effects of the SH-group blocker N-ethylmaleimide (NEM) and thiol group protector 1,4-dithioerythritol (DTE) on the redox status of cells HBL-100 cells, oxidative modification of their proteins and the state of glutathione and thioredoxin systems have been investigated. Breast epithelial cells cultivated in the presence of NEM were characterized by decreased redox status, increased glutathione reductase activity, and increased concentrations of products of irreversible oxidative modification of protein and amino acids. Cultivation of HBL-100 cells in the presence of DTE resulted in a shift of the redox status towards reduction processes and increased reversible protein modification by glutathionylation. The proposed model of intracellular redox modulation may be used in the development of new therapeutic approaches to treat diseases accompanied by impaired redox homeostasis (e.g. oncologic, inflammatory, cardiovascular and neurodegenerative disease).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:62 |
|---|---|
| Enthalten in: |
Biomeditsinskaia khimiia - 62(2016), 1 vom: 15. Jan., Seite 64-8 |
| Sprache: |
Russisch |
|---|
| Beteiligte Personen: |
Stepovaya, E A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
6892-68-8 |
|---|
| Anmerkungen: |
Date Completed 17.06.2016 Date Revised 23.10.2018 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.18097/PBMC20166201064 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM25838574X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM25838574X | ||
| 003 | DE-627 | ||
| 005 | 20231224184912.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2016 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.18097/PBMC20166201064 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0861.xml |
| 035 | |a (DE-627)NLM25838574X | ||
| 035 | |a (NLM)26973189 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 100 | 1 | |a Stepovaya, E A |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The role of oxidative protein modification and the gluthatione system in modulation of the redox status of breast epithelial cells |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.06.2016 | ||
| 500 | |a Date Revised 23.10.2018 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The effects of the SH-group blocker N-ethylmaleimide (NEM) and thiol group protector 1,4-dithioerythritol (DTE) on the redox status of cells HBL-100 cells, oxidative modification of their proteins and the state of glutathione and thioredoxin systems have been investigated. Breast epithelial cells cultivated in the presence of NEM were characterized by decreased redox status, increased glutathione reductase activity, and increased concentrations of products of irreversible oxidative modification of protein and amino acids. Cultivation of HBL-100 cells in the presence of DTE resulted in a shift of the redox status towards reduction processes and increased reversible protein modification by glutathionylation. The proposed model of intracellular redox modulation may be used in the development of new therapeutic approaches to treat diseases accompanied by impaired redox homeostasis (e.g. oncologic, inflammatory, cardiovascular and neurodegenerative disease) | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a breast epithelial cells | |
| 650 | 4 | |a cell redox status | |
| 650 | 4 | |a oxidative stress | |
| 650 | 4 | |a protein oxidative modification | |
| 650 | 7 | |a Dithioerythritol |2 NLM | |
| 650 | 7 | |a 6892-68-8 |2 NLM | |
| 650 | 7 | |a Glutathione |2 NLM | |
| 650 | 7 | |a GAN16C9B8O |2 NLM | |
| 700 | 1 | |a Shakhristova, E V |e verfasserin |4 aut | |
| 700 | 1 | |a Ryazantseva, N V |e verfasserin |4 aut | |
| 700 | 1 | |a Nosareva, O L |e verfasserin |4 aut | |
| 700 | 1 | |a Yakushina, V D |e verfasserin |4 aut | |
| 700 | 1 | |a Nosova, A I |e verfasserin |4 aut | |
| 700 | 1 | |a Gulaya, V S |e verfasserin |4 aut | |
| 700 | 1 | |a Stepanova, E A |e verfasserin |4 aut | |
| 700 | 1 | |a Chil'chigashev, R I |e verfasserin |4 aut | |
| 700 | 1 | |a Novitsky, V V |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biomeditsinskaia khimiia |d 2003 |g 62(2016), 1 vom: 15. Jan., Seite 64-8 |w (DE-627)NLM142863602 |x 2310-6972 |7 nnns |
| 773 | 1 | 8 | |g volume:62 |g year:2016 |g number:1 |g day:15 |g month:01 |g pages:64-8 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18097/PBMC20166201064 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 62 |j 2016 |e 1 |b 15 |c 01 |h 64-8 | ||